Vietnam MOH registration 2401177ĐKLH/BYT-HTTB
Drug Test for Qualitative Analysis of Cells Expressing HLA-DR Antigen
VN: Thuốc thử xét nghiệm định tính các tế bào biểu hiện kháng nguyên HLA-DR
Vietnam·Risk Class TTBYT Loại C·Anti-HLA-DR-Pacific Blue·Immunotech SAS·Registered Jul 22, 2024Registration details
- Analysis ID
- 2401177ĐKLH/BYT-HTTB
- Submission ID
- 000.00.04.G18-211129-0023
- Product Type
- Anti-HLA-DR-Pacific Blue
- Product Code
- B36291
Company information
- Manufacturer
- Immunotech SAS
- Manufacturer Country
- FRANCE
- Product Owner
- Beckman Coulter, Inc.
- Authorized Representative
- CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG
Technical details
- Intended Use
- Anti-HLA-DR-Pacific Blue, a combined antibody with fluorescent dye, enables the qualitative and quantitative determination of cell populations expressing the HLA-DR antigen in human biological samples using flow cytometry.
Dates and status
- Registration Date
- Jul 22, 2024
About this record
Access comprehensive regulatory information for Drug Test for Qualitative Analysis of Cells Expressing HLA-DR Antigen in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2401177ĐKLH/BYT-HTTB and manufactured by Immunotech SAS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI300,000+ Devices